Researchers at the Broad Institute and Jackson Laboratory successfully applied prime editing to correct five genetic mutations causing alternating hemiplegia of childhood (AHC) in mice. Treated animals showed significant reduction in symptoms and increased survival, marking the first therapeutic prime editing application in a neurological disease model. This breakthrough paves the way for gene editing approaches targeting complex neurological disorders.